Your browser doesn't support javascript.
loading
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release.
Lee, Eunhee; Lee, Shinai; Park, Sumyeong; Son, Yong-Gyu; Yoo, Jiseon; Koh, Youngil; Shin, Dong-Yeop; Lim, Yangmi; Won, Jonghwa.
Afiliação
  • Lee E; ABL Bio Inc, Seongnam, Korea (the Republic of).
  • Lee S; ABL Bio Inc, Seongnam, Korea (the Republic of).
  • Park S; ABL Bio Inc, Seongnam, Korea (the Republic of).
  • Son YG; ABL Bio Inc, Seongnam, Korea (the Republic of).
  • Yoo J; ABL Bio Inc, Seongnam, Korea (the Republic of).
  • Koh Y; Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of).
  • Shin DY; Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Korea (the Republic of).
  • Lim Y; ABL Bio Inc, Seongnam, Korea (the Republic of) jonghwa.won@ablbio.com yangmi.lim@ablbio.com.
  • Won J; ABL Bio Inc, Seongnam, Korea (the Republic of) jonghwa.won@ablbio.com yangmi.lim@ablbio.com.
J Immunother Cancer ; 11(10)2023 10.
Article em En | MEDLINE | ID: mdl-37848261
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Leucemia Mieloide Aguda / Anticorpos Biespecíficos Limite: Adult / Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Leucemia Mieloide Aguda / Anticorpos Biespecíficos Limite: Adult / Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article